News from glaxosmithkline plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 12, 2017, 10:55 ET GSK achieves approval for Nucala (mepolizumab) for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) for adults in the US

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as the first...


Nov 21, 2016, 07:00 ET GSK files regulatory submission in US for once-daily closed triple combination therapy FF/UMEC/VI for patients with COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the filing by GSK of a regulatory submission with the US Food...


Jun 02, 2016, 11:00 ET Regulatory update on US filing plans for closed triple combination therapy FF/UMEC/VI in patients with COPD

GlaxoSmithKline plc (LSE: GSK) and Innoviva, Inc. (Nasdaq: INVA) today announced that, following discussions with the US Food and Drug Administration ...


Feb 22, 2016, 11:06 ET GSK's Global HIV Business ViiV Healthcare Completes Transactions to Acquire Bristol-Myers Squibb's R&D HIV Assets

GlaxoSmithKline plc (LSE: GSK) today announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and...


Dec 02, 2015, 09:00 ET GSK Announces Nucala® (mepolizumab), Now Available In The Us For Sub-Group Of Patients With Severe Asthma

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Nucala® (mepolizumab), the first and only biologic add-on therapy for people 12 years and...


Nov 09, 2015, 08:00 ET GSK, COPD Foundation and AARC Team Up for #COPDChat, November 9th, 12 pm ET

GlaxoSmithKline plc (LSE: GSK) today announced a tweet chat with the COPD Foundation and American Association for Respiratory Care (AARC) to raise...


Apr 30, 2015, 04:36 ET FDA approves BREO® ELLIPTA® for the treatment of adults with asthma in the US

GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO®...


Jan 26, 2015, 09:17 ET GSK expands its portfolio of medicines in the US for patients with asthma and COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the simultaneous availability of two of its recently approved products for the treatment of...


Aug 26, 2014, 03:52 ET GSK receives FDA approval of an additional Promacta® (eltrombopag) indication for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST)

GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application ...


Jul 24, 2014, 01:32 ET FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Flonase® Allergy Relief...


Apr 30, 2014, 06:27 ET GSK receives approval for Incruse™ Ellipta® (umeclidinium) in the US for the treatment of COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Incruse™ Ellipta® (umeclidinium) as...


Apr 28, 2014, 08:54 ET Anoro™ Ellipta® now available in the US for treatment of COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that Anoro™ Ellipta® (umeclidinium and vilanterol inhalation...


Apr 15, 2014, 02:26 ET GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum™ (albiglutide)

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Tanzeum™ (albiglutide) for injection, ...


Dec 11, 2013, 05:55 ET New England Journal of Medicine releases study showing GSK's FluLaval Quadrivalent vaccine effective in preventing seasonal flu in children

GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that a peer-reviewed study issued online by the New England Journal of Medicine has reported that ...


Sep 18, 2013, 09:35 ET GlaxoSmithKline, Community Care of North Carolina harness "small data" to improve patient care and reduce health care costs

GlaxoSmithKline plc [LSE/NYSE: GSK] and Community Care of North Carolina (CCNC) today announced the initiation of a new approach to analyzing health...


Apr 17, 2013, 05:18 ET FDA Advisory Committee recommends approval of BREO™ ELLIPTA™ for the treatment of COPD

GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the Pulmonary-Allergy Drugs Advisory Committee (PADAC) to the ...


Dec 14, 2012, 05:41 ET GSK receives FDA approval for raxibacumab anti-toxin for the treatment of inhalational anthrax

GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of...


Dec 12, 2012, 09:00 ET GlaxoSmithKline advances multi-city discussion focused on improving the health of US communities

GlaxoSmithKline plc (LSE/NYSE: GSK) today proceeded with the next city stop in its national initiative to examine the barriers and identify...


Oct 24, 2012, 10:00 ET GlaxoSmithKline Launches New Program to Help Consumers Recycle Empty GSK Respiratory Inhalers

GlaxoSmithKline plc (LSE/NYSE: GSK) has introduced a new program to help consumers recycle their empty GSK respiratory inhalers and keep waste out of ...


Jul 02, 2012, 10:50 ET GlaxoSmithKline concludes previously announced agreement in principle to resolve multiple investigations with US Government and numerous states

GlaxoSmithKline plc (GSK) today announced that it has reached an agreement with the US Government, multiple states and the District of Columbia to...


Apr 26, 2012, 06:54 ET FDA approves Votrient® for treatment of patients with certain types of advanced soft tissue sarcoma

GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved Votrient® (pazopanib) for the...


Mar 31, 2011, 09:00 ET GSK Publishes Payments for Research, Consulting and Advising by U.S. Healthcare Professionals

laxoSmithKline (NYSE: GSK) today published a list of payments made during 2010 for clinical research studies led by U.S. healthcare professionals....


Jul 01, 2010, 12:16 ET GlaxoSmithKline and Genmab Announce Amendment to Ofatumumab Agreement

GlaxoSmithKline (NYSE and LSE: GSK) and Genmab A/S (OMX: GEN) announced today an amendment to the ofatumumab co-development and commercialisation...


Feb 01, 2010, 02:58 ET GSK 2009 Financial Results Announcement and Teleconference Details

On Thursday, February 4, 2010, GlaxoSmithKline plc will announce its full year financial results for the year ended December 31, 2009. It is...